Inventor
MERIT JEFFREY E
US17 patents
⚠️ This page may combine multiple inventors who share the name “MERIT JEFFREY E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
6 patentsUS11325891B2May 10, 2022
Processes and intermediates for preparing MCL1 inhibitors
GILEAD SCIENCES INC8 citations80
US11286257B2Mar 29, 2022
Processes for preparing toll-like receptor modulator compounds
GILEAD SCIENCES INC7 citations79
US11760736B2Sep 19, 2023
Processes and intermediates for preparing MCL1 inhibitors
GILEAD SCIENCES INC2 citations68
US12202782B2Jan 21, 2025
Processes and intermediates for preparing MCL1 inhibitors
GILEAD SCIENCES INC0 citations58
US12410146B2Sep 9, 2025
Processes and intermediates for preparing MCL1 inhibitors
GILEAD SCIENCES INC0 citations57
US12590089B2Mar 31, 2026
Processes for preparing toll-like receptor modulator compounds
GILEAD SCIENCES INC0 citations56
BREITENBUCHER J GUY
3 patentsUS8901111B2Dec 2, 2014
Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
BREITENBUCHER J GUY3 citations60
US8598356B2Dec 3, 2013
Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
BREITENBUCHER J GUY4 citations59
US8461159B2Jun 11, 2013
Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
BREITENBUCHER J GUY4 citations59
JANSSEN PHARMACEUTICA NV
3 patentsUS9738649B2Aug 22, 2017
Tetrahydro-pyrimidoazepines as modulators of TRPV1
JANSSEN PHARMACEUTICA NV0 citations51
US9422293B2Aug 23, 2016
Tetrahydro-pyrimidoazepines as modulators of TRPV1
JANSSEN PHARMACEUTICA NV0 citations51
US8877769B2Nov 4, 2014
Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
JANSSEN PHARMACEUTICA NV0 citations48